Summary. The ultrastructural co-localization of vasoactive intestinal polypeptide (VIP) and acetylcholine (ACh) -like cation was demonstrated in the rat endocrine pancreas. Immunoperoxidase cytochemical procedure for the detection of VIP was followed by ionic fixation of ACh by silicotungstic acid. All the VIPimmunoreactive nerve endings displayed punctiform precipitates revealing ACh-like cations in the small clear vesicles. Almost all the VIP-immunoreactive nerve terminals were in contact with endocrine A, B or D cells, but not in the close vicinity of blood vessels. Nerve endings devoid of VIP immunoreactivity but containing ACh-like cations were seen either in contact with endocrine cells or in close vicinity to blood vessels. These data suggest that VIP might modulate, concomitantly with ACh, the hormonal secretion of the endocrine pancreas, although the possibility of the neurosecretion of ACh and VIP into the blood vessels should not be excluded. ACh might also control some function of the endothelial cells of blood vessels.
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Histological studies have showed the abundance of nerve endings in the endocrine pancreas of various species (HONJIN, 1956; LEGG, 1968; LARSSON, 1979) . Ultrastructural observations (WATARI, 1968; KOBA-YASHI and FUJITA, 1969; SHORR and BLOOM, 1970; FUJITA and KOBAYASHI, 1979; RADKE and STACH, 1986) have revealed the presence of nerve endings in contact with endocrine cells and in close vicinity to the blood vessels. Physiological data showed a neural control of the secretion of endocrine cells (WOODS and PORTE, 1974) .
Vasoactive intestinal polypeptide (VIP), confirmed in nerve endings of the islets of Langerhans (LARSSoN, 1979) , may be implicated in neuro-endocrine transmission, as suggested by the presence of VIP receptors on endocrine cells (ANTEUNIS et al., 1986 (ANTEUNIS et al., , 1989 . VIP might also be subjected to neurosecretion into the blood capillaries of the islets (FUJITA and KOBAYASHI, 1979) . Different types of nerve endings, among them cholinergic (WATARI, 1968; SHORR and BLOOM, 1970; FUJITA and KOBAYASHI, 1979) and peptidergic ones (FUJITA and KOBAYASHI, 1979) were characterized by the morphology of the synaptic vesicles they contained. The cholinergic mechanisms are presumed to be modulated by neuropeptides, including VIP (LUNDBERG et al., 1980; LEBLANC et al., 1987) .
We performed a simultaneous ultrastructural localization of VIP immunoreactivity and acetylcholine (ACh)-like cations (ANGLADE and TSUJI, 1990) in order to precisely determine the location of the nerve endings containing VIP and/or ACh-like cations in rat endocrine pancreas. The synergic action of VIP and ACh on the endocrine cells is discussed.
MATERIALS AND METHODS
Adult wistar rats were killed by exsanguination under ether anaesthesia. Segments of the pancreas were removed and fixed by immersion in an icecooled solution of 4% paraformaldehyde and 0.25% glutaraldehyde in 0.1M phosphate buffer, pH 7.2, for 3-4h. After washing in 0.2M phosphate buffer, the During this study, Dr. P. ANGLADE was supported by a grant-in-aid for scientific research provided by the "Japan Society for the Promotion of Science". 554 P. ANGLADE and S. TSUJI: pieces of pancreas were impregnated by 10% gelatin in phosphate buffer at 37t for 1h. Post-fixation of gelatin embedded tissues was performed in the same fixative for 1h. After rinsing in 0.2M phosphate buffer, pH 7.2, 50um thick vibratome sections were obtained in 0.01M phosphate buffer saline (PBS), pH 7.2.
At first, the immunocytochemical reaction to evidence VIP was performed by means of a peroxidaseantiperoxidase immunocytochemical procedure (STERNBERGER et al., 1970) . After immersion in 0.1% Triton X-100 in PBS for 2h, the tissues were soaked in normal goat serum (dilution 1: 20 in PBS) for 1 h and in the specific antiserum raised against VIP (dilution 1:500, R-502 Yanaihara or INCSTAR E2261) for 16-48h at 4C. The tissues were then treated with goat secondary anti-rabbit antibodies for 2h (dilution 1:100). The peroxidase activity of the immunocomplex was revealed with a method modified from GRAHAM and KARNOVSKY (1966) : 3-5mg of diaminobenzidine tetrahydrochloride (DAB) was dissolved in 10ml of PBS in which the tissues were immersed for 10min. Then H2O2 was added to the DAB solution to a final concentration of 0.01% (w/v). The tissues were washed in PBS after each step of incubation.
After VIP immunocytochemical reaction, the ionic fixation of ACh-like cations was performed on the same sections: tissues were immersed in a 5% aqueous solution of silicotungstic acid for 30min and then in a mixture of 2.5% silicotungstic acid and 2% osmium tetroxide for 30min. After washing in water and dehydration in graded series of ethanol solutions, tissues were embedded in Epon. Ultrathin sections were observed without counterstaining under a JEOL 200CX electron microscope at 80kV.
Controls for the immunocytochemical reactions were made by replacing the specific anti-VIP antiserum by normal rabbit serum or by preincubating the specific anti-VIP antiserum with 10-5M VIP.
RESULTS

VIP-immunoreactive
nerve endings were readily identified owing to the dark precipitates of DAB they displayed. The controls for immunocytochemical reaction (omission of specific anti-VIP antibody or preabsorption with VIP) did not display any immunoreactivity.
Almost all the VIP-immunoreactive nerve endings were located in contact with A, B and D endocrine cells, but not in the close vicinity of blood vessels (Figs. 1-6 ). Some VIP-immunoreactive nerve endings were observed in contact with two different types of endocrine cells (Figs. 1, 2) . No specialized synaptic structure could be recognized between the nerve terminals and the endocrine cells. All the VIPimmunoreactive nerve endings observed contained punctiform precipitates indicating the presence of ACh-like cations fixed by silicotungstic acid. These precipitates were located in the small clear vesicles of the nerve terminals (Figs. 2, 4, 6 ).
One part of the nerve endings containing punctiform precipitates did not show any immunoreactivity for VIP (Figs. 7-10 ). These nerve terminals were situated either in contact with endocrine cells (Figs. 7, 8) or/and in the vicinity of blood vessels (Figs. 7-10 ). Other nerve endings devoid of both VIP immunoreactivity and punctif orm precipitates were observed in the vicinity of endocrine cells (Figs. 9, 10) .
DISCUSSION
The present data demonstrated VIP nerve terminals in contact with endocrine cells in the rat pancreas. ACh-like cations were localized in all the VIP nerve terminals. In addition, nerve terminals containing ACh but not VIP immunoreactivity were also observ- ed in contact with endocrine cells. The presence of ACh in both VIP-immunoreactive and non-immunoreactive nerve terminals was previously observed in the rat myenteric plexus (ANGLADE and TSUJI, 1990) . The nerve terminals devoid of both VIP immunoreactivity and ACh-like cations, observed less frequently than cholinergic ones (SHORR and BLOOM, 1970) , presumably contain other neurotransmitters such as catecholamines.
According to the physiological data, stimulation of vagus nerves or the application of cholinergic agents modulate the release of insulin and glucagon from endocrine cells (WOODS and PORTE, 1974) . VIP has also been shown to modulate the action of glucose on the release of insulin, glucagon and somatostatin (SCHEBALIN et al., 1977; SZECOWKA et al., 1980 SZECOWKA et al., , 1983 . In this case, VIP likely acts as a neuromediator binding to the specific receptors on endocrine cells (ANTEUNIS et al., 1986 (ANTEUNIS et al., , 1989 . Therefore, the present data suggest a neural control of hormonal secretion by ACh and VIP, which are released from nerve endings in contact with endocrine cells. ACh and VIP may act in synergy, as has already been observed in different tissues (LUND-BERG et al., 1980; LEBLANC et al., 1987) . However, the precise mechanism of the synergic action is not known.
The present findings do not exclude the possible release of neurosubstances into the blood (FUJITA and KOBAYASHI, 1979) and to the endothelial cells of the blood vessels. Particularly, ACh could control some function of the endothelial cells. The presence of nerve endings containing ACh-like rations in the vicinity of the endothelial cells and of muscarinic cholinergic receptors on the wall of the noninnervated vasculature (FURCHGOTT, 1984) supports such a possibility.
